Skip to main content
. 2024 May 6;37(5):2627–2634. doi: 10.1007/s10278-024-01100-2

Fig. 1.

Fig. 1

Example of how HP.13C MRI can be used in a workflow for improved targeting of biopsies in prostate cancer [11]. Using DICOM has been critical in the success of this workflow, as this allows for integration into PACS as well as the fusion biopsy platform, with radiologists and urologists easily able to review the images and resulting annotations outlining the biopsy targets. Figure reproduced with permission from [11].